drug

Venlafaxine

as of 2026-07-01

Add to landscape Monitor this Compare this Ask about this

at a glance

small molecule

Pre-approval / investigational in the US

Developed by Dr. Inge Winter

2 trials in the graph

Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality

small molecule

Indications

Investigational (via trials)

Schizophrenia Depression Psychosomatic Disorders Bipolar Disorder Schizophrenia and Related Disorders Schizophrenia Anxiety Disorders Depressive Disorder, Major Depression Major Depressive Disorder Psychophysiologic Disorders Dementia Bipolar Depression Anxiety Disorders Dementia

Trials

Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure

NCT05603104Phase 3Recruiting

Pharmacovigilance in Gerontopsychiatric Patients

NCT02374567Phase 3Terminated

KOLs & investigators

Helge Frieling, Prof., MDKOL score 5

Facts & assertions

0 sourced

No assertions recorded for this entity.

relationships

The graph out of here

developer

Dr. Inge Winter

company

trial

Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure

PHASE3

trial

Pharmacovigilance in Gerontopsychiatric Patients

PHASE3

trial

indication

Schizophrenia

indication

Depression

indication

Psychosomatic Disorders

indication

Bipolar Disorder

indication

KOL

Helge Frieling, Prof., MD

KOL score 5

person